# US 2026/0151632 A1 · Systems and methods for direct suppression of nerve cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0151632 A1
- Document ID: US20260151632A1
- Status: Published application
- Kind: A1
- Application number: 19/383,987
- Filed: 2025-11-10
- Published: 2026-06-04
- Earliest claimed: 2020-01-25
- Assignees: Nevro Corporation
- Applicants: Nevro Corp.
- Inventors: Kerry Bradley; Dongchul Lee
- Web page: https://patentgrep.com/patent/US20260151632A1

## CPC

- A61N 1/36071: {Pain}
- A61N 1/36062: {Spinal stimulation}
- A61N 1/36146: {specified by the stimulation parameters}
- A61N 1/36175: {Pulse width or duty cycle}
- A61N 1/36192: {Amplitude modulation}
- A61N 1/0551: {Spinal or peripheral nerve electrodes}
- A61N 1/3616: {Voltage density or current density}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.

## Claims

### Claim 1

A patient treatment system, comprising:
a signal generator having a computer readable storage medium with instructions that, in operation, generate a therapy signal having a pulse width in a pulse width range from about 5 ms to about 2 seconds; and
a signal delivery element coupleable to the signal generator, wherein the signal delivery element is positionable proximate a spinal cord region, and, in operation, delivers the therapy signal to the spinal cord region to suppress at least a subset of neurons at or proximate the spinal cord region, the subset of neurons includes WDR neurons.

### Claim 2 (depends on 1)

The pain treatment system of claim 1 wherein the subset of neurons further includes NS neurons.

### Claim 3 (depends on 1)

The patient treatment system of claim 1 wherein the therapy signal has an amplitude below an activation threshold of the subset of neurons.

### Claim 4 (depends on 1)

The patient treatment system of claim 1 wherein the therapy signal includes a plurality of biphasic pulses having an anodic pulse phase and a cathodic pulse phase, and wherein at least one of the anodic pulse phase or the cathodic pulse phase has the pulse width in the pulse width range from about 5 ms to about 2 seconds.

### Claim 5 (depends on 4)

The patient treatment system of claim 4 wherein the biphasic pulses include a ramping period between the anodic pulse phase and the cathodic pulse phase.

### Claim 6 (depends on 5)

The patient treatment system of claim 5 wherein the ramping period has a duration generally equal to the pulse width.

### Claim 7 (depends on 4)

The patient treatment system of claim 4 wherein the anodic pulse phase and the cathodic pulse phase have different pulse widths and/or amplitudes.

### Claim 8 (depends on 4)

The patient treatment system of claim 4 wherein the anodic pulse phase and the cathodic pulse phase have the same pulse width and amplitude.

### Claim 9 (depends on 1)

The patient treatment system of claim 1 wherein the therapy signal includes a plurality of monophasic pulses, and wherein the plurality of monophasic pulses have the pulse width in the pulse width range from about 5 ms to about 2 seconds.

### Claim 10 (depends on 1)

The patient treatment system of claim 1 wherein the pulse width is about 50 ms or greater.

### Claim 11 (depends on 1)

The patient treatment system of claim 1 wherein the pulse width range is from about 5 ms to about 100 ms.

### Claim 12 (depends on 1)

The patient treatment system of claim 1 wherein the pulse width is about 100 ms or greater.

### Claim 13 (depends on 1)

The patient treatment system of claim 1 wherein the pulse width is about 500 ms or greater.

### Claim 14

A patient treatment system, comprising:
a signal generator having a computer readable storage medium with instructions that, in operation, generate a therapy signal having (i) a pulse width in a pulse width range from about 5 ms to about 2 seconds, and (ii) an amplitude below an activation threshold of target neurons; and
a signal delivery element coupleable to the signal generator, wherein the signal delivery element is positionable proximate a spinal cord region, and, in operation, delivers the therapy signal to the spinal cord region to suppress at least a subset of the target neurons, wherein the electrode delivers individual pulses of the therapy signal at a charge density less than or equal to 300 μC/cm2.

### Claim 15 (depends on 14)

The patient treatment system of claim 14 wherein the signal delivery element includes an electrode, and wherein the electrode is uncoated.

### Claim 16 (depends on 14)

The patient treatment system of claim 14 wherein the signal delivery element includes an electrode, and wherein the electrode delivers individual pulses of the therapy signal at a charge density less than or equal to 300 μC/cm2.

### Claim 17 (depends on 14)

The patient treatment system of claim 14 wherein the signal delivery element includes an electrode, and wherein the instructions are a first set of instructions, the system further comprising a controller with a second set of instructions that, in operation, calculate a maximum amplitude based at least in part on the pulse width, a material of the electrode, a surface area of the electrode, and/or an impedance value associated with the electrode, wherein the maximum amplitude corresponds to a maximum charge density tolerated by the electrode, and wherein the amplitude of the therapy signal is less than or equal to the maximum amplitude.

### Claim 18 (depends on 14)

The patient treatment system of claim 14 wherein the subset of neurons includes WDR neurons.

### Claim 19 (depends on 14)

The patient treatment system of claim 14 wherein the subset of neurons includes NS neurons.

### Claim 20 (depends on 14)

The patient treatment system of claim 14 wherein the therapy signal includes a plurality of biphasic pulses having an anodic pulse phase and a cathodic pulse phase, and wherein at least one of the anodic pulse phase or the cathodic pulse phase has the pulse width in the pulse width range from about 5 ms to about 2 seconds.
